B Cells and Plasma Cells: Fundamental and Translational Biology
NIAID - National Institute of Allergy and Infectious Diseases
About This Grant
Abstract Support is requested for a Keystone Symposia conference entitled “B Cells and Plasma Cells: Fundamental and Translational Biology,” organized by Drs. Kim Good-Jacobson, Deepta Bhattacharya and Taras Kreslavsky, with scientific programming input from Keystone Symposia. The meeting will take place March 16–18, 2026 at Keystone Resort in Keystone, Colorado, USA. B cells play a fundamental role in human health and longevity, and are essential for creating long-lasting immunity, with plasma cells and memory B cells providing protection against reinfection. However, when B cells malfunction during chronic infection, autoimmunity, and lymphomas, they can drive immunopathogenesis and disease. This Keystone Symposia conference will discuss recent advances in understanding what makes B cell responses last longer and work better. The meeting will also explore how these discoveries can be used to specifically target B cells for therapeutic intervention and utilize antibodies for diagnostics and immunotherapies. Understanding these mechanisms has become even more timely, given newly emerging pathogens and their variants, the expanding portfolio of vaccine platforms, and the need to engineer the B cell response for more effective therapeutics. The program has been designed to serve as a guide for building effective B cell responses and will feature interdisciplinary talks on B cell roles in vaccine design, mechanisms for promoting long-lasting immune memory, understanding harmful antibody production, and new therapeutic strategies to treat immunologic diseases and develop effective therapeutics to improve public health. This Keystone Symposia meeting will bring together global experts in the biology of plasma cells and memory B cells to present the latest research on how productive antibody responses are mounted, their role in combating infectious diseases, and their dysfunction in allergy and autoimmunity. Accordingly, this conference will be held jointly with the Keystone Symposia conference, “B and T Cell Collaboration in Lymphoid and Nonlymphoid Microenvironments,” enabling cross-disciplinary insights and encouraging innovative collaborations towards identifying novel therapeutic targets.
Grant Summary
B Cells and Plasma Cells: Fundamental and Translational Biology is a NIAID - National Institute of Allergy and Infectious Diseases grant providing up to $16K for university, nonprofit, healthcare org. Applications are due 2027-01-31 (open). Check eligibility and apply with FindGrants.
Not quite the right fit?
Search 9,000+ open grants, or get matches ranked for your organization — free.
Focus Areas
Eligibility
How to Apply
Up to $16K
2027-01-31
- 1Confirm your organization is eligible for B Cells and Plasma Cells: Fundamental and Translational Biology from NIAID - National Institute of Allergy and Infectious Diseases, checking organization type, location, and any population or project requirements.
- 2Gather the required documents and information, including your organization details, project plan, and budget figures.
- 3Draft your application narrative and budget addressing the funder's priorities and review criteria. FindGrants can draft each section for you to review and edit.
- 4Review every section against the requirements checklist, then export a submission-ready application pack and submit it to NIAID - National Institute of Allergy and Infectious Diseases before the deadline.
Don't want to draft it yourself?
We'll draft the complete application against NIAID - National Institute of Allergy and Infectious Diseases's requirements, run a quality review, and email you a submission-ready PDF plus an editable Word doc within 5 business days. Most orders deliver in 24-48 hours. Flat $399, any grant size.
AI Requirement Analysis
Detailed requirements not yet analyzed
Have the NOFO? Paste it below for AI-powered requirement analysis.
B Cells and Plasma Cells: Fundamental and Translational Biology: Frequently Asked Questions
Who is eligible for the B Cells and Plasma Cells: Fundamental and Translational Biology?
B Cells and Plasma Cells: Fundamental and Translational Biology is offered by NIAID - National Institute of Allergy and Infectious Diseases and is generally open to university, nonprofit, healthcare org. It is open to organizations nationwide unless the funder specifies otherwise. Review the specific eligibility terms before applying, since funders set their own requirements around organization type, location, and the population or project being served.
How much funding does the B Cells and Plasma Cells: Fundamental and Translational Biology provide?
B Cells and Plasma Cells: Fundamental and Translational Biology provides up to $16K per award from NIAID - National Institute of Allergy and Infectious Diseases. Actual award sizes depend on the scope of your project, available program funds, and the number of applicants, so build a budget that reflects realistic, allowable costs rather than the maximum figure.
When is the B Cells and Plasma Cells: Fundamental and Translational Biology deadline?
Applications for B Cells and Plasma Cells: Fundamental and Translational Biology are due 2027-01-31 (open). Because deadlines can change, verify the date with the funder, NIAID - National Institute of Allergy and Infectious Diseases, and give yourself enough time to prepare a complete, competitive application before the close date.
How do you apply for the B Cells and Plasma Cells: Fundamental and Translational Biology?
To apply for B Cells and Plasma Cells: Fundamental and Translational Biology, confirm your eligibility, gather the required documents, and prepare a narrative and budget that address the funder's priorities. FindGrants guides you step by step and can draft each section, then exports a submission-ready application pack for this grant from NIAID - National Institute of Allergy and Infectious Diseases.